Misuse of Drugs Act 1975

If you need more information about this Act, please contact the administering agency: Ministry of Health

Schedule 2 Class B controlled drugs

s 2(1)

Part 1

1 The following substances, namely:

AB-CHMINACA

AB-FUBINACA

AB-PINACA

5F-AKB-48

AM-2201

Amphetamine (2-amino-1-phenylpropane)

Cannabis preparations: that is, any preparation containing any tetrahydrocannabinols, including cannabis resin (commonly known as hashish) and cannabis oil (commonly know as hash oil), produced by subjecting cannabis plant material to any kind of processing (but does not include a CBD product)

N-ethyl pentylone

Ethylone

JWH-018

MDMA (2-methylamino-1-(3,4-methylenedioxyphenyl) propane)

MDMB-CHMICA

Methcathinone

Morphine

MT-45

25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine)

25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine)

25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine)

Opium

Para-methoxymethylamphetamine (PMMA)

5F-PB-22

Tetrahydrocannabinols, except when contained in a Class C controlled drug or a CBD product

UR-144

XLR-11.

Schedule 2 Part 1 clause 1 AB-CHMINACA: inserted, on 15 December 2022, by clause 5(1) of the Misuse of Drugs (Classification and Presumption of Supply) Order 2022 (SL 2022/35).

Schedule 2 Part 1 clause 1 AB-FUBINACA: inserted, on 15 December 2022, by clause 5(1) of the Misuse of Drugs (Classification and Presumption of Supply) Order 2022 (SL 2022/35).

Schedule 2 Part 1 clause 1 AB-PINACA: inserted, on 15 December 2022, by clause 5(1) of the Misuse of Drugs (Classification and Presumption of Supply) Order 2022 (SL 2022/35).

Schedule 2 Part 1 clause 1 5F-AKB-48: inserted, on 15 December 2022, by clause 5(1) of the Misuse of Drugs (Classification and Presumption of Supply) Order 2022 (SL 2022/35).

Schedule 2 Part 1 clause 1 AM-2201: inserted, on 15 December 2022, by clause 5(1) of the Misuse of Drugs (Classification and Presumption of Supply) Order 2022 (SL 2022/35).

Schedule 2 Part 1 clause 1 Amphetamine: inserted, on 9 September 2005, by clause 4(1) of the Misuse of Drugs (Changes to Controlled Drugs) Order 2005 (SR 2005/175).

Schedule 2 Part 1 clause 1 Cannabis: replaced, on 13 January 1983, by section 7 of the Misuse of Drugs Amendment Act 1982 (1982 No 151).

Schedule 2 Part 1 clause 1 Cannabis: amended, on 18 December 2018, by section 11(1)(a) of the Misuse of Drugs (Medicinal Cannabis) Amendment Act 2018 (2018 No 54).

Schedule 2 Part 1 clause 1 Cocaine: repealed, on 13 January 1988, by section 9(1) of the Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193).

Schedule 2 Part 1 clause 1 N-ethyl pentylone: inserted, on 15 December 2022, by clause 5(1) of the Misuse of Drugs (Classification and Presumption of Supply) Order 2022 (SL 2022/35).

Schedule 2 Part 1 clause 1 Ethylone: inserted, on 15 December 2022, by clause 5(1) of the Misuse of Drugs (Classification and Presumption of Supply) Order 2022 (SL 2022/35).

Schedule 2 Part 1 clause 1 JWH-018: inserted, on 15 December 2022, by clause 5(1) of the Misuse of Drugs (Classification and Presumption of Supply) Order 2022 (SL 2022/35).

Schedule 2 Part 1 clause 1 MDMA: inserted, on 9 September 2005, by clause 4(1) of the Misuse of Drugs (Changes to Controlled Drugs) Order 2005 (SR 2005/175).

Schedule 2 Part 1 clause 1 MDMB-CHMICA: inserted, on 15 December 2022, by clause 5(1) of the Misuse of Drugs (Classification and Presumption of Supply) Order 2022 (SL 2022/35).

Schedule 2 Part 1 clause 1 Methcathinone: inserted, on 30 May 2003, by clause 5(1) of the Misuse of Drugs (Changes to Controlled Drugs) Order 2003 (SR 2003/47).

Schedule 2 Part 1 clause 1 MT-45: inserted, on 15 December 2022, by clause 5(1) of the Misuse of Drugs (Classification and Presumption of Supply) Order 2022 (SL 2022/35).

Schedule 2 Part 1 clause 1 25B-NBOMe: inserted, on 22 December 2016, by clause 3 of the Misuse of Drugs (Classification and Presumption of Supply—25B-NBOMe, 25C-NBOMe, and 25I-NBOMe) Order 2016 (LI 2016/89).

Schedule 2 Part 1 clause 1 25C-NBOMe: inserted, on 22 December 2016, by clause 3 of the Misuse of Drugs (Classification and Presumption of Supply—25B-NBOMe, 25C-NBOMe, and 25I-NBOMe) Order 2016 (LI 2016/89).

Schedule 2 Part 1 clause 1 25I-NBOMe: inserted, on 22 December 2016, by clause 3 of the Misuse of Drugs (Classification and Presumption of Supply—25B-NBOMe, 25C-NBOMe, and 25I-NBOMe) Order 2016 (LI 2016/89).

Schedule 2 Part 1 clause 1 Para-methoxymethylamphetamine: inserted, on 15 December 2022, by clause 5(1) of the Misuse of Drugs (Classification and Presumption of Supply) Order 2022 (SL 2022/35).

Schedule 2 Part 1 clause 1 5F-PB-22: inserted, on 15 December 2022, by clause 5(1) of the Misuse of Drugs (Classification and Presumption of Supply) Order 2022 (SL 2022/35).

Schedule 2 Part 1 clause 1 Tetrahydrocannabinols: inserted, on 2 September 1996, by section 7(1) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

Schedule 2 Part 1 clause 1 Tetrahydrocannabinols: amended, on 18 December 2018, by section 11(1)(b) of the Misuse of Drugs (Medicinal Cannabis) Amendment Act 2018 (2018 No 54).

Schedule 2 Part 1 clause 1 UR-144: inserted, on 15 December 2022, by clause 5(1) of the Misuse of Drugs (Classification and Presumption of Supply) Order 2022 (SL 2022/35).

Schedule 2 Part 1 clause 1 XLR-11: inserted, on 15 December 2022, by clause 5(1) of the Misuse of Drugs (Classification and Presumption of Supply) Order 2022 (SL 2022/35).

2

The isomers of the substances mentioned in clause 1 whenever the existence of such isomers is possible within the specific chemical designation, except for isomers of tetrahydrocannabinols if the isomers naturally occur in cannabis and are not capable of inducing more than a minor psychoactive effect, by any means, in a person.

Schedule 2 Part 1 clause 2: amended, on 18 December 2018, by section 11(2) of the Misuse of Drugs (Medicinal Cannabis) Amendment Act 2018 (2018 No 54).

Schedule 2 Part 1 clause 2: amended, on 31 May 2002, by clause 3(2)(a) of the Misuse of Drugs (Classification of Fantasy) Order 2001 (SR 2001/383).

3

The esters and ethers of the substances mentioned in clause 1 and the esters and ethers of the isomers mentioned in clause 2 whenever the existence of such esters or ethers is possible, except for esters and ethers of tetrahydrocannabinols or of isomers of tetrahydrocannabinols if the esters and ethers naturally occur in cannabis and are not capable of inducing more than a minor psychoactive effect, by any means, in a person.

Schedule 2 Part 1 clause 3: amended, on 18 December 2018, by section 11(3) of the Misuse of Drugs (Medicinal Cannabis) Amendment Act 2018 (2018 No 54).

Schedule 2 Part 1 clause 3: amended, on 31 May 2002, by clause 3(2)(b) of the Misuse of Drugs (Classification of Fantasy) Order 2001 (SR 2001/383).

4

The salts of the substances mentioned in clause 1 and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3, except for the salts of tetrahydrocannabinols or the salts of the substances excluded from clauses 2 and 3 if the salts naturally occur in cannabis and are not capable of inducing more than a minor psychoactive effect, by any means, in a person.

Schedule 2 Part 1 clause 4: amended, on 18 December 2018, by section 11(4) of the Misuse of Drugs (Medicinal Cannabis) Amendment Act 2018 (2018 No 54).

Schedule 2 Part 1 clause 4: amended, on 31 May 2002, by clause 3(2)(c) of the Misuse of Drugs (Classification of Fantasy) Order 2001 (SR 2001/383).

5

Substances containing any proportion of a substance mentioned in clause 1, clause 2, clause 3, or clause 4.

6

The substance gamma-hydroxybutyrate (GHB) (commonly known as fantasy) and—

(a)

the esters, ethers, and amides of GHB; and

(b)

all substances from which GHB can be derived, including (without limitation)—

(i)

1,4-butanediol:

(ii)

gamma-aminobutyric acid:

(iii)

gamma-butyrolactone:

(iv)

gamma-hydroxybutyraldehyde; and

(c)

the salts of GHB (including sodium oxybate) and the salts of any substance referred to in paragraph (a) or paragraph (b); and

(d)

any substance, preparation, or mixture containing any proportion of GHB or any substance referred to in any of paragraphs (a) to (c).

Schedule 2 Part 1 clause 6: inserted, on 31 May 2002, by clause 3(1) of the Misuse of Drugs (Classification of Fantasy) Order 2001 (SR 2001/383).

Part 2

1 The following substances, namely:

Benzphetamine (2-benzylmethylamino-1-phenylpropane)

Cathinone (2-amino-1-phenylpropan-1-one)

DOET (2-amino-1-(2,5-dimethoxy-4-ethylphenyl) propane)

Ephedrine

N-ethyl MDA (2-ethylamino-1-(3,4-methylenedioxyphenyl) propane)

N-ethylamphetamine (2-ethylamino-1-phenylpropane)

Fencamfamine (N-ethyl-3-phenylbicyclo[2.2.1]heptan-2-amine)

Fenethylline (3,7-dihydro-1,3-dimethyl-7-[2-[(1-methyl-2-phenylethyl)-amino]ethyl]-1H-purine-2,6-dione)

Fenproporex (2-(2-cyanoethylamino)-1-phenylpropane)

N-hydroxy MDA (2-hydroxyamino-1-(3,4-methylenedioxyphenyl) propane)

Lisdexamfetamine

Mefenorex (2-(3-chloropropylamino)-1-phenylpropane)

Mephedrone

Methaqualone (2-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone)

4-methylaminorex (cis-2-amino-4-methyl-5-phenyl-2-oxazoline)

Methylone

Methylphenidate (α-phenyl-2-piperidineacetic acid methyl ester)

4-methylthioamphetamine

Norpseudoephedrine (threo-2-amino-1-hydroxy-1-phenylpropane), including cathine

Propylhexedrine (1-cyclohexyl-2-methylaminopropane)

Pseudoephedrine

Pyrovalerone (1-(4-methylphenyl)-2-(1-pyrrolidinyl)-1-pentanone).

Schedule 2 Part 2 clause 1: replaced, on 13 January 1988, by section 9(2) of the Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193).

Schedule 2 Part 2 clause 1 Amphetamine: repealed, on 9 September 2005, by clause 4(2) of the Misuse of Drugs (Changes to Controlled Drugs) Order 2005 (SR 2005/175).

Schedule 2 Part 2 clause 1 Ephedrine: inserted, on 8 September 2011, by section 8 of the Misuse of Drugs Amendment Act (No 2) 2011 (2011 No 54).

Schedule 2 Part 2 clause 1 N-ethyl MDA: inserted, on 2 September 1996, by section 7(3) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

Schedule 2 Part 2 clause 1 N-hydroxy MDA: inserted, on 2 September 1996, by section 7(3) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

Schedule 2 Part 2 clause 1 Lisdexamfetamine: inserted, on 15 December 2022, by clause 5(2) of the Misuse of Drugs (Classification and Presumption of Supply) Order 2022 (SL 2022/35).

Schedule 2 Part 2 clause 1 MDMA: repealed, on 9 September 2005, by clause 4(2) of the Misuse of Drugs (Changes to Controlled Drugs) Order 2005 (SR 2005/175).

Schedule 2 Part 2 clause 1 Mephedrone: inserted, on 15 December 2022, by clause 5(2) of the Misuse of Drugs (Classification and Presumption of Supply) Order 2022 (SL 2022/35).

Schedule 2 Part 2 clause 1 Methamphetamine: repealed, on 30 May 2003, by clause 5(2) of the Misuse of Drugs (Changes to Controlled Drugs) Order 2003 (SR 2003/47).

Schedule 2 Part 2 clause 1 4-methylaminorex: inserted, on 2 September 1996, by section 7(3) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

Schedule 2 Part 2 clause 1 Methylone: inserted, on 15 December 2022, by clause 5(2) of the Misuse of Drugs (Classification and Presumption of Supply) Order 2022 (SL 2022/35).

Schedule 2 Part 2 clause 1 4-methylthioamphetamine: inserted, on 30 May 2003, by clause 5(3) of the Misuse of Drugs (Changes to Controlled Drugs) Order 2003 (SR 2003/47).

Schedule 2 Part 2 clause 1 Norpseudoephedrine: replaced, on 2 September 1996, by section 7(2) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

Schedule 2 Part 2 clause 1 Pseudoephedrine: inserted, on 8 September 2011, by section 8 of the Misuse of Drugs Amendment Act (No 2) 2011 (2011 No 54).

2

The isomers of the substances mentioned in this Part whenever the existence of such isomers is possible within the specific chemical designation.

3

The esters and ethers of the substances mentioned in this Part and the esters and ethers of the isomers mentioned in clause 2 whenever the existence of such esters or ethers is possible.

4

The salts of the substances mentioned in this Part and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3.

5

Substances containing any proportion of a substance mentioned in clause 1, clause 2, clause 3, or clause 4.

Part 3

1 The following substances, namely:

Acetyl-α-methylfentanyl (N-[1-(α-methylphenethyl]-4-piperidyl] acetanilide)

Acetylmethadol (3-acetoxy-6-dimethylamino-4,4-diphenylheptane)

Alfentanil (N-[1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-(tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidinyl]-N-phenylpropanamide)

Allylprodine (3-allyl-1-methyl-4-phenyl-4-propionoxypiperidine)

Alphacetylmethadol (α-3-acetoxy-6-dimethylamino-4,4-diphenylheptane)

Alphameprodine (α-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine)

Alphamethadol (α-6-dimethylamino-4,4-diphenyl-3-heptanol)

Alphaprodine (α-1,3-dimethyl-4-phenyl-4-propionoxypiperidine)

Anileridine (1-para-aminophenethyl-4-phenylpiperidine-4-carboxylic acid ethyl ester)

Benzethidine (1-(2-benzyloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester)

Benzylmorphine (3-benzylmorphine)

Betacetylmethadol (β-3-acetoxy-6-dimethylamino-4,4-diphenylheptane)

Betameprodine (β-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine)

Betamethadol (β-6-dimethylamino-4,4-diphenyl-3-heptanol)

Betaprodine (β-1,3-dimethyl-4-phenyl-4-propionoxypiperidine)

Bezitramide (1-(3-cyano-3,3-diphenylpropyl)-4-(2-oxo-3-propionyl-1-benzimidazolinyl)piperidine)

Clonitazene (2-para-chlorbenzyl-1-diethylaminoethyl-5-nitrobenzimidazole)

Codoxime (dihydrocodeinone-6-carboxymethyloxime)

Concentrate of poppy straw—that is, the material arising when parts of any plant of the species Papaver somniferum have entered a process for the concentration of the alkaloids

Dextromoramide ((+)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl) butyl] morpholine)

Diampromide (N-[2-(methylphenethylamino) propyl] propionanilide)

Diethylthiambutene (3-diethylamino-1,1-di-(2′-thienyl)-1-butene).

Difenoxin (1-(3-cyano-3, 3 diphenylpropyl)-4-phenylisonipecotic acid)

Dihydromorphine

Dimenoxadol (2-dimethylaminoethyl 1-ethoxy-1, 1-diphenylacetate)

Dimepheptanol (6-dimethylamino-4,4-diphenyl-3-heptanol)

Dimethylthiambutene (3-dimethylamino-1,1-di-(2′-thienyl)-1-butene)

Dioxaphetyl butyrate (ethyl 4-morpholino-2, 2-diphenylbutyrate)

Diphenoxylate (1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester)

Dipipanone (4,4-diphenyl-6-piperidine-3-heptanone)

Drotebanol (3,4-dimethoxy-17-methylmorphinan-6β, 14-diol)

Ecgonine, its esters and derivatives which are convertible to ecgonine and cocaine, except when contained in a Class C controlled drug

Ethylmethylthiambutene (3-ethylmethylamino-1,1-di-(2′-thienyl)-1-butene)

Etonitazene (1-diethylaminoethyl-2-para-ethoxybenzyl-5-nitrobenzimidazole)

Etoxeridine (1-[2-(2-hydroxyethoxy)ethyl]-4-phenylpiperidine-4-carboxylic acid ethyl ester)

Fentanyl (1-phenethyl-4-(N-propionylanilino)piperidine)

p-fluorofentanyl (4′-fluoro-N-1-(phenethyl-4-piperidyl) propionanilide)

Furethidine (1-(2-tetrahydrofurfuryloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester)

Hydrocodone (dihydrocodeinone)

Hydromorphinol (14-hydroxydihydromorphine)

Hydromorphone (dihydromorphinone)

β-hydroxyfentanyl (N-[1-(β-hydroxyphenethyl)-4-piperidyl] propionanilide)

β-hydroxy-3-methylfentanyl (N-[1-(β-hydroxyphenethyl)-3-methyl-4-piperidyl]propionanilide)

Hydroxypethidine (4-meta-hydroxyphenyl-1-methylpiperidine-4-carboxylic acid ethyl ester)

Isomethadone (6-dimethylamino-5-methyl-4,4-diphenyl-3-hexanone)

Levomethorphan ((−)-3-methoxy-N-methylmorphinan) but not including dextromethorphan ((+)-3-methoxy-N-methylmorphinan) and dextrorphan ((+)-3-hydroxy-N-methylmorphinan)

Levomoramide ((−)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl) butyl] morpholine)

Levophenacylmorphan ((−)-3-hydroxy-N-phenacylmorphinan)

Levorphanol ((−)-3-hydroxy-N-methylmorphinan)

Mecloqualone (3-(2-chlorophenyl)-2-methyl-4-(3H)-quinazolinone)

Metazocine (2′-hydroxy-2,5,9-trimethyl-6,7-benzomorphan)

Methadone (6-dimethylamino-4,4-diphenyl-3-heptanone)

Methadone-intermediate (4-cyano-2-dimethylamino-4,4-diphenylbutane)

1-methyl-4-phenyl-4-piperidinol

Methyldesorphine (6-methyl-Δ6-deoxymorphine)

Methyldihydromorphine (6-methyldihydromorphine)

α-methylfentanyl (N-[1-(α-methylphenethyl)-4-piperidyl]propionanilide)

3-methylfentanyl (N-[3-methyl-1-phenethyl-4-piperidyl] propionanilide)

α-methylthiofentanyl (N-[1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidyl]propionanilide)

3-methylthiofentanyl (N-[3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide)

Metopon (5-methyldihydromorphinone)

Moramide-intermediate (2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid)

Morpheridine (1-(2-morpholinoethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester)

Morphine methobromide and other pentavalent nitrogen morphine derivatives

Morphine-n-oxide

MPPP (1-methyl-4-phenyl-4-piperidinol propionate (ester))

Myrophine (myristylbenzylmorphine)

Nabilone (trans-3-(1-1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6, 6-dimethyl-9H-dibenzo[b,d] pyran-9-one)

Nicomorphine (3,6-dinicotinylmorphine)

Noracymethadol (α-3-acetoxy-6-methylamino-4,4-diphenylheptane)

Norlevorphanol ((−)-3-hydroxymorphinan)

Normethadone (6-dimethylamino-4,4-diphenyl-3-hexanone)

Normorphine (demethylmorphine)

Norpipanone (4,4-diphenyl-6-piperidino-3-hexanone)

Oxycodone (14-hydroxydihydrocodeinone)

Oxymorphone (14-hydroxydihydromorphinone)

PEPAP (1-phenethyl-4-phenyl-4-piperidinol acetate (ester))

Pethidine (1-methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester)

Pethidine-intermediate-A (4-cyano-1-methyl-4-phenylpiperidine)

Pethidine-intermediate-B (4-phenylpiperidine-4-carboxylic acid ethyl ester)

Pethidine-intermediate-C (1-methyl-4-phenylpiperidine-4-carboxylic acid)

Phenadoxone (6-morpholino-4,4diphenyl-3-heptanone)

Phenampromide (N-(1-methyl-2-piperidinoethyl) propionanilide)

Phenazocine (2′-hydroxy-5,9-dimethyl-2-phenethyl-6,7-benzomorphan)

Phendimetrazine (3,4-dimethyl-2-phenylmorpholine)

1-phenethyl-4-phenyl-4-piperidinol

Phenmetrazine (3-methyl-2-phenylmorpholine)

Phenomorphan (3-hydroxy-N-phenethylmorphinan)

Phenoperidine (1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester)

Piminodine (4-phenyl-1-(3-phenylaminopropyl)piperidine-4-carboxylic acid ethyl ester)

Piritramide (1-(3-cyano-3,3-diphenylpropyl)-4-(1-piperidino) piperidine-4-carboxylic acid amide)

Proheptazine (1,3-dimethyl-4-phenyl-4-propionoxyazacycloheptane)

Properidine (1-methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester)

Racemethorphan ((±)-3-methoxy-N-methylmorphinan)

Racemoramide ((±) -4- [2-methyl-4-oxo-3, 3-diphenyl-4-(1-pyrrolidinyl) butyl] morpholine)

Racemorphan ((±)-3-hydroxy-N-methylmorphinan)

Remifentanil (1-(2-methoxycarbornyl-ethyl)-4-(phenylpropionyl-amino)-piperidine-4-carboxylic acid methyl ester)

Sufentanil (N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl] propionanilide)

Tapentadol (3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol hydrochloride)

Thebacon (acetyldihydrocodeinone)

Thebaine

Thiofentanyl (N-[1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide)

Tilidine ((±)-ethyl trans-2-(dimethylamino)-1-phenyl-3-cyclohexene-1-carboxylate)

Trimeperidine (1,2,5-trimethyl-4-phenyl-4-propionoxypiperidine).

Schedule 2 Part 3 clause 1 Acetyl-α-methylfentanyl: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

Schedule 2 Part 3 clause 1 Alfentanil: inserted, on 6 November 1986, by section 4 of the Misuse of Drugs Amendment Act 1986 (1986 No 102).

Schedule 2 Part 3 clause 1 p-fluorofentanyl: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

Schedule 2 Part 3 clause 1 β-hydroxyfentanyl: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

Schedule 2 Part 3 clause 1 β-hydroxy-3-methylfentanyl: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

Schedule 2 Part 3 clause 1 Mecloqualone: inserted, on 21 May 1981, by clause 3(2) of the Misuse of Drugs Order 1981 (SR 1981/114).

Schedule 2 Part 3 clause 1 1-methyl-4-phenyl-4-piperidinol: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

Schedule 2 Part 3 clause 1 α-methylfentanyl: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

Schedule 2 Part 3 clause 1 3-methylfentanyl: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

Schedule 2 Part 3 clause 1 α-methylthiofentanyl: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

Schedule 2 Part 3 clause 1 3-methylthiofentanyl: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

Schedule 2 Part 3 clause 1 MPPP: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

Schedule 2 Part 3 clause 1 Nabilone: inserted, on 13 January 1988, by section 9(3) of the Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193).

Schedule 2 Part 3 clause 1 PEPAP: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

Schedule 2 Part 3 clause 1 1-phenethyl-4-phenyl-4-piperidinol: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

Schedule 2 Part 3 clause 1 Remifentanil: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

Schedule 2 Part 3 clause 1 Sufentanil: inserted, on 21 May 1981, by clause 3(2) of the Misuse of Drugs Order 1981 (SR 1981/114).

Schedule 2 Part 3 clause 1 Tapentadol: inserted, on 1 May 2012, by clause 3 of the Misuse of Drugs (Classification of Tapentadol) Order 2011 (SR 2011/247).

Schedule 2 Part 3 clause 1 Thiofentanyl: inserted, on 2 September 1996, by section 7(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

Schedule 2 Part 3 clause 1 Tilidine: inserted, on 21 May 1981, by clause 3(2) of the Misuse of Drugs Order 1981 (SR 1981/114).

2

The isomers of the substances mentioned in this Part whenever the existence of such isomers is possible within the specific chemical designation.

3

The esters and ethers of the substances mentioned in this Part and the esters and ethers of the isomers mentioned in clause 2 whenever the existence of such esters or ethers is possible.

4

The salts of the substances mentioned in this Part and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3.

5

Substances containing any proportion of a substance mentioned in clause 1, clause 2, clause 3, or clause 4.